PBH Prestige Consumer Healthcare Inc
Price (delayed)
$84.21
Market cap
$4.17B
P/E Ratio
19.54
Dividend/share
N/A
EPS
$4.31
Enterprise value
$5.15B
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company's diverse portfolio
Highlights
The company's debt fell by 15% YoY and by 3.2% QoQ
The quick ratio has increased by 14% YoY and by 6% from the previous quarter
PBH's P/E is 36% above its 5-year quarterly average of 14.4 and 12% above its last 4 quarters average of 17.4
Key stats
What are the main financial stats of PBH
Market
Valuations
Earnings
Shares outstanding
49.54M
Market cap
$4.17B
Enterprise value
$5.15B
Price to earnings (P/E)
19.54
Price to book (P/B)
2.33
Price to sales (P/S)
3.73
EV/EBIT
15.61
EV/EBITDA
14.01
EV/Sales
4.6
Revenue
$1.12B
Gross profit
$616.27M
Operating income
$330.5M
Net income
$213.94M
EBIT
$329.69M
EBITDA
$367.43M
Free cash flow
$248.69M
Per share
Balance sheet
Liquidity
EPS
$4.31
EPS diluted
$4.27
Free cash flow per share
$5.01
Book value per share
$36.2
Revenue per share
$22.55
TBVPS
$9.91
Total assets
$3.33B
Total liabilities
$1.54B
Debt
$1.03B
Equity
$1.79B
Working capital
$274.62M
Debt to equity
0.57
Current ratio
3.68
Quick ratio
2.13
Net debt/EBITDA
2.66
Margins
Efficiency
Dividend
EBITDA margin
32.9%
Gross margin
55.1%
Net margin
19.1%
Operating margin
29.6%
Return on assets
6.4%
Return on equity
12.5%
Return on invested capital
23.5%
Return on capital employed
10.2%
Return on sales
29.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PBH stock price
How has the Prestige Consumer Healthcare stock price performed over time
Intraday
-0.18%
1 week
0.62%
1 month
-0.5%
1 year
13.97%
YTD
7.84%
QTD
7.84%
Financial performance
How have Prestige Consumer Healthcare's revenue and profit performed over time
Revenue
$1.12B
Gross profit
$616.27M
Operating income
$330.5M
Net income
$213.94M
Gross margin
55.1%
Net margin
19.1%
The net income has grown by 3.9% from the previous quarter
The company's net margin rose by 3.2% QoQ
Growth
What is Prestige Consumer Healthcare's growth rate over time
Valuation
What is Prestige Consumer Healthcare stock price valuation
P/E
19.54
P/B
2.33
P/S
3.73
EV/EBIT
15.61
EV/EBITDA
14.01
EV/Sales
4.6
PBH's P/E is 36% above its 5-year quarterly average of 14.4 and 12% above its last 4 quarters average of 17.4
The EPS has grown by 3.9% from the previous quarter
PBH's price to book (P/B) is 29% higher than its 5-year quarterly average of 1.8 and 11% higher than its last 4 quarters average of 2.1
The equity has grown by 12% YoY and by 3.3% from the previous quarter
The price to sales (P/S) is 43% higher than the 5-year quarterly average of 2.6 and 17% higher than the last 4 quarters average of 3.2
Efficiency
How efficient is Prestige Consumer Healthcare business performance
Prestige Consumer Healthcare's ROIC has increased by 4% from the previous quarter
Prestige Consumer Healthcare's return on assets has increased by 3.2% QoQ
Dividends
What is PBH's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Prestige Consumer Healthcare financials performed over time
Prestige Consumer Healthcare's total assets is 116% higher than its total liabilities
The current ratio is up by 19% year-on-year and by 3.4% since the previous quarter
The quick ratio has increased by 14% YoY and by 6% from the previous quarter
The company's debt is 43% lower than its equity
Prestige Consumer Healthcare's debt to equity has decreased by 25% YoY and by 7% from the previous quarter
The company's debt fell by 15% YoY and by 3.2% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.